To ask Her Majesty's Government whether they intend to introduce a system for reporting adverse reactions to psychiatric and psychological treatments similar to the Yellow Card Scheme for medicines; and if not, why not.
Answered on
19 June 2018
There are no current plans to introduce a separate scheme for reporting adverse reactions to psychiatric and psychological treatments. The Yellow Card Scheme already includes a facility to report suspected adverse incidents associated with products used in psychiatric and psychological treatments.
The National Institute for Health and Care Excellence (NICE) produces guidance for the National Health Service on how to treat certain health conditions, including mental health conditions and NICE clinical guidelines provide advice on the care and support that should be offered to people who use health and care services, including some therapeutic interventions for mental health. NICE guidance is based on a thorough assessment of the available evidence and is developed through extensive engagement with stakeholders. NHS organisations are expected to take it fully into account in the design of services to meet the needs of their populations.
NICE’s Quality Standard 14 - Service user experience in adult mental health services states that service providers should ensure systems are in place to collect feedback on the experience of care from service users and their families or carers. A copy of the Quality Standard is attached.